In a thought-provoking paper, Ehninger, Neff and their coworkers made a claim that rapamycin has the capability of extending lifespan as well as aging albeit to a certain degree. This JCI paper showed that rapamycin has the capability of slowing the aging process thereby extending lifespan despite its express anti-cancer activities. The aging process is MTOR-driven in part, which is a pointless prolongation of developmental expansion. According to the paper rapamycin affects similar processes in both the young and old animals. This is in the young animal’s phenotypes and traits, which prolongations turn harmful, hyperfunctional and lethal later on.
Dr. Blagosklonny’s Preparation for Oncology
Mikhail Blagosklonny is a professor, researcher and philanthropist. He is also a normal person with a desire to ensure that people from around the world get access to top notch treatment despite their economical status. Dr. Blagosklonny is particularly interested in medical research and focuses on aging and cancer. He is interested in finding the connection between the two as well as the reasons why cancer is more widespread in individuals whose ages are advanced especially once they are past a definite age. Mikhail Blagosklonny conducts research that proves to be useful in the oncology field today and will continue being in the future.
Mikhail Blagosklonny’s Research
Mikhail Blagosklonny is an influential person not only in his field as a researcher but also as an expert and professor in the field. He is an inspiration to both his students and peers especially those who wish to further their knowledge in his research in future. Dr. Blagosklonny picked interesting topics touching on aging and cancer. These topics attracted a lot of attention in the medical field and more so on impactjournals.com. Mikhail Blagosklonny is working on finding the best way to treating cancer effectively without exposing patients to huge costs and excruciating pain, synonymous with the available methods today. He is hoping that he will be able to find a way that will ensure the elimination of cancerous cells without destroying the body’s normal cells that are important for its recovery. This will be beneficial as these body cells are extremely important to the patients since their bodies require them for recovery after the long duration of undergoing conventional cancer treatment.
Progress of Mikhail Blagosklonny’s Research
Blagosklonny has so far made a lot of progress within his area of interest and hopes that other upcoming researchers will be inspired by his works to further his research. He hopes interested researchers will look to further his research on tandfonline.com. Mikhail Blagosklonny holds the belief that cancer treatment will soon not be viewed as a luxury for those who are wealthy but all people will afford it. He is working on developing a cost-effective and easy treatment in the fight against cancer.
To know more click here